Recombinant DNA Advisory Committee - 06/7-8/93 
Tom Porter, Theragen, Inc. 
Raj Puri, Food and Drug Administration 
Corey Raffel, Childrens Hospital of Los Angeles 
Judy Randall, Economists Magazine 
Robert Ratcheson, Case Western Reserve University 
Michael Ravitch, Treatment Action Group 
Rex Rhein, Biotechnology Newswatch 
Jon Richards, University of Chicago 
Paul Robbins, University of Pittsburgh 
Renee Rockman, Genetic Therapy, Inc. 
Igor Roninson, University of Illinois 
H. John Roth, Department of Agriculture 
Bruce Schackman, Furman Selz, Inc. 
Alain Schreiber, Vical Inc. 
Hilliard Seigler, Duke University 
G. Terry Sharrer, Smithsonian Institution 
Joseph Sherwin, Thomas Jefferson University 
Tomiko Shimada, Ambience Awareness International 
Thomas Storch, Tulane University Medical Center 
Nevin Summers, Massachusetts Institute of Technology 
Gary Temple, Life Technologies, Inc. 
Pierre Tiberghien, CRTS Besancon, France 
Paul Tolstoshev, Genetic Therapy, Inc. 
Arvilla Trag, Virogenetics, Inc. 
Mark Tykocinski, Case Western Reserve University 
Christine Van de Pol, Rhone-Poulenc Rorer, Inc. 
Trish Waitschies, MD Anderson Cancer Research Center 
John Warner, Viagene, Inc. 
Jody Waugh, The Novus Group 
Julie Werner, The Novus Group 
Clyde White, Carolina Biological Supply Co. 
Hong-Ji Xu, Baylor College of Medicine 
[548] 
Recombinant DNA Research, Volume 17 
